Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Submitted 5 months ago by realcaseyrollins to Finance
https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html
Submitted 5 months ago by realcaseyrollins to Finance
https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html